Related Experiment Video
Updated: Jan 14, 2026
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Harnessing Adipose Ferroptosis: A Promising Novel Pathway for Obesity Treatment
Mohammed Zayed1,2,3, Ahmed Massoud4, Fatma Hassan5,6
1Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, 54531, Republic of Korea. mzayed2@vet.svu.edu.eg.
Purpose Of Review:
This review summarizes the potential of targeting ferroptosis-iron-dependent lipid peroxidation-as a novel strategy for treating obesity and its metabolic complications through mechanisms different from traditional interventions.
Recent Findings:
Recent preclinical studies show that selectively inducing ferroptosis in lipid-rich adipocytes and obese mice can effectively decrease fat mass and enhance metabolic health. These ferroptosis-based methods target the fundamental cellular processes of adipocyte dysfunction, affecting lipid metabolism and reducing oxidative stress. The strategy appears promising in addressing major metabolic issues such as insulin resistance and hepatic steatosis. In addition, the ability to customize ferroptosis inducers based on individual metabolic profiles offers a pathway to highly personalized obesity treatments. Ferroptosis agonists offer a revolutionary therapeutic approach for obesity treatment by directly reducing fat mass and targeting key metabolic issues. However, applying these findings in clinical settings requires careful evaluation of the long-term safety and effects of pharmacological ferroptosis induction. This review highlights important gaps in current knowledge and suggests future research directions crucial for developing these innovative therapies.
Insights
Targeting ferroptosis, an iron-dependent cell death, shows promise for obesity treatment. Inducing ferroptosis in fat cells can reduce fat mass and improve metabolic health, offering a novel therapeutic strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Disorders
Background:
- Obesity is a complex metabolic disorder with significant health implications.
- Traditional interventions for obesity have limitations.
- Ferroptosis, a regulated form of cell death dependent on iron and lipid peroxidation, is emerging as a potential therapeutic target.
Purpose of the Study:
- To review the potential of targeting ferroptosis for obesity treatment.
- To explore ferroptosis-inducing mechanisms distinct from conventional therapies.
- To assess ferroptosis-based strategies for metabolic complications associated with obesity.
Main Methods:
- Review of preclinical studies on ferroptosis induction in adipocytes and obese models.
- Analysis of ferroptosis's impact on lipid metabolism and oxidative stress.
- Evaluation of ferroptosis agonists for personalized obesity treatment.
Main Results:
- Selective ferroptosis induction in adipocytes and obese mice effectively reduces fat mass.
- Ferroptosis-targeting strategies improve metabolic health, including insulin resistance and hepatic steatosis.
- Customizable ferroptosis inducers offer potential for personalized obesity therapies.
Conclusions:
- Ferroptosis agonists represent a novel therapeutic approach for obesity by directly reducing fat mass and addressing key metabolic issues.
- Further research is needed to evaluate the long-term safety and efficacy of pharmacological ferroptosis induction in clinical settings.
- Identifying knowledge gaps and future research directions is crucial for developing ferroptosis-based obesity treatments.
